About the course
Course Type
Executive Leadership | AI Governance Capstone Simulation
Institution
C-Lab Institute
Overview
Artificial Intelligence in healthcare does not merely optimise processes — it directly influences diagnoses, treatment decisions, patient safety, and institutional trust.
This capstone is the culminating stage of the C-Lab Institute AI Responsibility pathway. Participants step into the role of senior leadership at Meridian Health Network, a nationally recognised hospital group facing a pivotal decision: whether to deploy an AI-powered diagnostic triage system in its emergency departments
ai-responsibility-capstone-clin…
.
The AI system promises:
• 18% improvement in overall diagnostic accuracy
• Faster triage and reduced emergency department wait times
• Improved resource allocation
• Enhanced operational efficiency
However, pilot findings and stakeholder review raise serious concerns:
• Reduced diagnostic accuracy for elderly female patients
• Limited explainability of model outputs
• Complex cross-jurisdictional data sourcing
• Pending national clinical AI guidelines
• Increasing scrutiny from regulators and patient advocates
• Internal pressure from marketing and finance to deploy quickly
The board must determine whether to:
Deploy system-wide,
Restrict to advisory-only use,
Delay pending safeguards and explainability improvements,
Or suspend deployment until regulatory clarity emerges
ai-responsibility-capstone-clin…
.
This is not a technical optimisation exercise.
It is a governance decision under clinical, ethical, regulatory, and reputational pressure — where patient lives are directly affected.
Capstone Objective
Participants will act as Chair of the AI Risk & Governance Committee and prepare a formal Board Memorandum advising Meridian Health Network on a responsible course of action
ai-responsibility-capstone-clin…
.
The capstone evaluates the leader’s ability to:
• Identify clinical safety and equity risks
• Assess disparities in system performance
• Evaluate regulatory and legal exposure (HIPAA, GDPR, cross-border data issues)
• Address explainability and transparency limitations
• Design governance safeguards and oversight structures
• Recommend a defensible deployment decision
What Participants Must Submit
A structured 1,800–2,000 word Executive Board Memorandum addressing the following sections:
1. Clinical & Ethical Risk Analysis
• Diagnostic accuracy risks
• Performance disparities across patient populations
• Patient safety implications
• Fairness and equity considerations
• Transparency and informed consent challenges
2. Regulatory & Legal Exposure
• Health data protection compliance
• Cross-jurisdictional data governance
• Clinical liability implications
• Pending regulatory frameworks
• Documentation and audit readiness
3. Governance Safeguards
• Bias monitoring mechanisms
• Ongoing model validation and performance audits
• Explainability protocols
• Clinician-in-the-loop requirements
• Stakeholder engagement (clinicians, patients, technical teams)
4. Oversight Structure
• AI Oversight Committee reporting to the Board
• Defined accountability across clinical, risk, IT, and compliance functions
• Escalation and incident reporting procedures
• Internal and external audit mechanisms
• Independent review processes
5. Deployment Recommendation
Clear recommendation:
Deploy across network
Restrict to advisory use
Delay until safeguards implemented
Suspend pending regulatory clarity
Participants must justify:
• Conditions required for safe deployment
• Phased rollout strategy (if applicable)
• Monitoring and performance metrics
• 12-month governance roadmap
Reflection
“What does responsible AI leadership require when innovation promises clinical gains — but patient safety, equity, and trust remain uncertain?”
Assessment Criteria
Submissions are evaluated on:
• Depth of Clinical & Risk Analysis
• Regulatory and Legal Awareness
• Strength of Governance Design
• Balance Between Innovation and Patient Safety
• Clarity and Defensibility of Deployment Decision
• Executive-Level Strategic Judgment
Award
🏅 300 Responsibility Coins
🎓 C-Lab Institute AI Responsibility Capstone Certificate
What you'll learn
- Risk Analysis: Identify clinical safety threats, demographic biases, and gaps in AI validation studies.
- Regulatory Navigation: Evaluate institutional exposure to regulatory requirements and medical liability.
- Governance Design: Construct oversight committees with clear accountability between clinical and technical staff.
- Operational Safeguards: Implement "human-in-the-loop" protocols and adverse event reporting systems.
- Strategic Decision-Making: Formulate defensible recommendations to continue, restrict, or pause AI deployment.
- Compliance Roadmapping: Develop 12-month monitoring plans to ensure long-term AI transparency and safety.
Requirements
- Programme Alignment: C-Lab AI Leadership Pathway – Responsibility Stage
- Coin Allocation: Responsibility Coins
- Prerequisite: Completion of AI Readiness for Leaders
Course content
Capstone Objective
Participants will act as Chair of the Clinical AI Oversight Committee and prepare a formal Regulatory & Board Advisory Memorandum recommending a responsible course of action.
The capstone evaluates the leader’s ability to:
• Identify patient safety and clinical risk
• Assess validation, bias, and model performance concerns
• Evaluate regulatory compliance exposure
• Design oversight, audit, and accountability structures
• Propose monitoring and escalation mechanisms
• Make a defensible deployment / pause recommendation
Award
🏅 300 Responsibility Coins
📜 C-Lab Institute AI Responsibility Capstone Certificate
Primary 3R Dimension: Responsibility (Do)
Progression Path: Leader → Fellow
Enrolment options
AI Responsibility Capstone: Clinical AI Under Regulatory Scrutiny - Healthcare Case Study
Course Type
Executive Leadership | AI Governance Capstone Simulation
Institution
C-Lab Institute
Overview
Artificial Intelligence in healthcare does not merely optimise processes — it directly influences diagnoses, treatment decisions, patient safety, and institutional trust.
This capstone is the culminating stage of the C-Lab Institute AI Responsibility pathway. Participants step into the role of senior leadership at Meridian Health Network, a nationally recognised hospital group facing a pivotal decision: whether to deploy an AI-powered diagnostic triage system in its emergency departments
ai-responsibility-capstone-clin…
.
The AI system promises:
• 18% improvement in overall diagnostic accuracy
• Faster triage and reduced emergency department wait times
• Improved resource allocation
• Enhanced operational efficiency
However, pilot findings and stakeholder review raise serious concerns:
• Reduced diagnostic accuracy for elderly female patients
• Limited explainability of model outputs
• Complex cross-jurisdictional data sourcing
• Pending national clinical AI guidelines
• Increasing scrutiny from regulators and patient advocates
• Internal pressure from marketing and finance to deploy quickly
The board must determine whether to:
Deploy system-wide,
Restrict to advisory-only use,
Delay pending safeguards and explainability improvements,
Or suspend deployment until regulatory clarity emerges
ai-responsibility-capstone-clin…
.
This is not a technical optimisation exercise.
It is a governance decision under clinical, ethical, regulatory, and reputational pressure — where patient lives are directly affected.
Capstone Objective
Participants will act as Chair of the AI Risk & Governance Committee and prepare a formal Board Memorandum advising Meridian Health Network on a responsible course of action
ai-responsibility-capstone-clin…
.
The capstone evaluates the leader’s ability to:
• Identify clinical safety and equity risks
• Assess disparities in system performance
• Evaluate regulatory and legal exposure (HIPAA, GDPR, cross-border data issues)
• Address explainability and transparency limitations
• Design governance safeguards and oversight structures
• Recommend a defensible deployment decision
What Participants Must Submit
A structured 1,800–2,000 word Executive Board Memorandum addressing the following sections:
1. Clinical & Ethical Risk Analysis
• Diagnostic accuracy risks
• Performance disparities across patient populations
• Patient safety implications
• Fairness and equity considerations
• Transparency and informed consent challenges
2. Regulatory & Legal Exposure
• Health data protection compliance
• Cross-jurisdictional data governance
• Clinical liability implications
• Pending regulatory frameworks
• Documentation and audit readiness
3. Governance Safeguards
• Bias monitoring mechanisms
• Ongoing model validation and performance audits
• Explainability protocols
• Clinician-in-the-loop requirements
• Stakeholder engagement (clinicians, patients, technical teams)
4. Oversight Structure
• AI Oversight Committee reporting to the Board
• Defined accountability across clinical, risk, IT, and compliance functions
• Escalation and incident reporting procedures
• Internal and external audit mechanisms
• Independent review processes
5. Deployment Recommendation
Clear recommendation:
Deploy across network
Restrict to advisory use
Delay until safeguards implemented
Suspend pending regulatory clarity
Participants must justify:
• Conditions required for safe deployment
• Phased rollout strategy (if applicable)
• Monitoring and performance metrics
• 12-month governance roadmap
Reflection
“What does responsible AI leadership require when innovation promises clinical gains — but patient safety, equity, and trust remain uncertain?”
Assessment Criteria
Submissions are evaluated on:
• Depth of Clinical & Risk Analysis
• Regulatory and Legal Awareness
• Strength of Governance Design
• Balance Between Innovation and Patient Safety
• Clarity and Defensibility of Deployment Decision
• Executive-Level Strategic Judgment
Award
🏅 300 Responsibility Coins
🎓 C-Lab Institute AI Responsibility Capstone Certificate
- Enrolled students: There are no students enrolled in this course.
